No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Chemicals - Specialty
Established in Thane, India, in 1957, Advanced Enzyme Technologies Limited (which adopted its current name in 2005, previously known as Advanced Biochemicals Limited) is a global leader in the discovery, creation, and distribution of enzymes and probiotics. The company's operations span India, the United States, Asia, Europe, and other international territories. Its extensive range of enzymatic products serves a wide array of applications, including human health and animal nutrition, as well as numerous food processing industries such as fruit and vegetable, baking, brewing and malting, grain processing, protein modification, yeast processing, dairy and cheese production, and oils and fats processing, alongside various specialized uses. Furthermore, Advanced Enzyme Technologies supplies non-food enzymes vital for sectors like textile manufacturing, leather processing, pulp and paper production, detergents and cleaning agents, bio-fuels, and biocatalysis.
www.advancedenzymes.comNo one on the platform currently holds ADVENZYMES.BO.
No tracked institution reports a position in ADVENZYMES.BO as of their last filing.
No one on the platform has traded ADVENZYMES.BO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 9.0% | 10.0% | 14.5% | — | — | — |
| Rev. Growth % | 17.1% | 8.3% | ||||
| Profit Margin % | 22.6% | 21.3% | 24.2% | |||
| Free Cash Flow Margin % | 16.1% | 17.4% | 22.0% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $8.7B | +19.1% | $14.80 | $14.80–$14.80 | — | 1 |
| 2028 | $10.1B | +16.6% | $17.50 | $17.50–$17.50 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| ADVENZYMES.BOAdvanced Enzyme Technologies Limited | $290.50 | +0.66% | $32.6B | — |
| CAMLINFINE.BOCamlin Fine Sciences Limited | $99.00 | -0.20% | $19.0B | — |
| CAMLINFINE.NSCamlin Fine Sciences Limited | $100.30 | +1.10% | $19.3B | — |
| GRAUWEIL.BOGrauer & Weil (India) Limited | $72.99 | -0.19% | $33.1B | — |
| POCL.BOPondy Oxides And Chemicals Limited | $456.00 | +4.84% | $34.9B | — |
| POCL.NSPondy Oxides And Chemicals Limited |
Source: Financial Modeling Prep · peers by sector/industry
| $459.25 |
| +5.50% |
| $35.0B |
| — |
| PREMEXPLN.NSPremier Explosives Limited | $667.50 | -0.12% | $35.9B | — |